Subscribe
shutterstock_1644424099_angellodeco
angellodeco / Shutterstock.com
23 March 2020EuropeSarah Morgan

Ventilator maker offers up IP to tackle shortage

UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
UK govt backs ventilator makers against potential IP complaints
16 April 2020   The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

More on this story

Medtech
UK govt backs ventilator makers against potential IP complaints
16 April 2020   The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

More on this story

Medtech
UK govt backs ventilator makers against potential IP complaints
16 April 2020   The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?